https://www.recursion.com/ | United States | 2013 | $509.79M
Recursion is a US-based clinical-stage biotechnology company that is leveraging the convergence of experimental biology, automation, and artificial intelligence to efficiently discover and develop potential drug candidates across a wide range of indications. The company’s integrated platform and AI research engine, Valence Labs, have the potential to transform the drug discovery and development process, making it more scalable, reliable, and impactful for patients.
